Assistance Publique Hopitaux De Paris

The Assistance Publique Hopitaux De Paris site in Paris conducts a strong portfolio in nephrology, focusing on kidney-related disorders and transplant care. Trials here are exploring ways to better protect kidney function, slow disease progression, and improve outcomes for patients with both chronic and immune-mediated renal conditions.

• Focal segmental glomerulosclerosis and idiopathic immune complex mediated membranoproliferative glomerulonephritis: testing new approaches to reduce proteinuria and preserve kidney function
• ANCA-associated vasculitis and chronic kidney disease: evaluating treatments aimed at limiting renal damage and improving blood pressure control
• Kidney transplant: studying strategies to prevent rejection and support better post-transplant outcomes

These studies reflect a clear emphasis on improving kidney health through better treatment effectiveness, disease control, and long-term renal protection.

Research in cardiovascular diseases at this site includes prevention and treatment studies for patients at elevated risk of heart attack, stroke, and heart failure. The work spans both common cardiovascular conditions and more specialized clotting-related disorders.

• Atherosclerotic cardiovascular disease and atrial fibrillation: evaluating therapies to reduce major cardiovascular events and prevent stroke
• Heart failure and pediatric pulmonary hypertension: assessing treatments that may improve cardiac function and delay disease progression
• Hemic and lymphatic diseases: studying safer and more effective ways to prevent bleeding in patients with hemophilia

The overall goal is to improve prevention, symptom control, and long-term outcomes in patients with high-risk cardiovascular and coagulation disorders.

A major part of the research portfolio covers neoplasms and hematologic cancers, with trials in solid tumors and blood cancers. These studies are designed to test new cancer therapies, refine peri-operative treatment, and improve disease-free and progression-free survival.

• Prostate cancer, breast cancer, and colon cancer: evaluating new treatment combinations and peri-operative strategies
• Acute myeloid leukemia, multiple myeloma, follicular lymphoma, and marginal zone lymphoma: testing novel anti-cancer agents and combination regimens
• Renal cell carcinoma and head and neck squamous cell carcinoma: studying adjuvant and neoadjuvant approaches to improve cancer control

Much of this work focuses on improving treatment effectiveness while aiming to reduce recurrence and extend survival.

The site also supports studies in respiratory diseases, virus diseases, and immune system diseases, reflecting a broad interest in chronic lung disorders, difficult infections, and immune-related complications. Several trials are aimed at better symptom management and longer-term disease control.

• Idiopathic pulmonary fibrosis, fibrotic lung disease, and pulmonary arterial hypertension: assessing therapies that may slow progression and improve breathing capacity
• HIV-1 infection and progressive multifocal leukoencephalopathy: studying treatment strategies in complex infectious disease settings
• Mycobacterium xenopi pulmonary infection and cystic fibrosis: evaluating approaches to improve infection control and long-term respiratory health

These trials highlight a focus on improving functional outcomes, controlling chronic infection, and supporting patients with serious immune and lung conditions.

Another important area of research involves congenital, hereditary, and neonatal diseases, with a strong emphasis on rare disorders across childhood and adulthood. The studies aim to expand treatment options where effective therapies are limited or still emerging.

• Osteogenesis imperfecta and congenital hyperinsulinism: evaluating therapies to improve bone strength and stabilize blood sugar
• Epidermolysis bullosa and Netherton syndrome: testing new treatments for severe inherited skin conditions
• Hereditary hemophilia and pediatric herpes zoster prevention: studying prevention and supportive care in vulnerable patient groups

At Assistance Publique Hopitaux De Paris, these trials are centered on safer care, symptom relief, and better quality of life for patients living with rare and often lifelong conditions.

Clinical trials in digestive system diseases and nutritional and metabolic diseases address inflammatory bowel disease, obesity, and metabolic complications. The research aims to improve disease control and reduce the burden of long-term complications.

• Crohn's disease: studying new options for patients who have not responded well to standard therapies
• Obesity and overweight: evaluating treatments intended to improve weight-related health outcomes
• Congenital hyperinsulinism: investigating better control of low blood sugar episodes in children

These studies are designed to support more effective symptom management and better everyday health for patients with chronic digestive and metabolic disorders.